| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 11 |
| 1 | PREDNISOLONE ORAL | 11 |
| 2 | PREDNISOLONE ORAL SOLUTION | 11 |
| 3 | PREDNISONE | 11 |
| 4 | METHOTREXATE SODIUM | 10 |
| 5 | ADALIMUMAB | 8 |
| 6 | CYCLOPHOSPHAMIDE | 8 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 9 | TACROLIMUS | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METEX | 1 | 0.0026 |
| 1 | SODIUM POLYSTYRENE SULFONATE | 3 | 0.0019 |
| 2 | GLOFITAMAB | 1 | 0.0004 |
| 3 | MELPHALAN HYDROCHLORIDE | 7 | 0.0003 |
| 4 | MYCOPHENILIC ACID | 3 | 0.0001 |
| 5 | ENFORTUMAB VEDOTIN | 1 | 0.0001 |
| 6 | BUSULFAN | 2 | 0.0001 |
| 7 | MESNA INJECTION | 1 | 0.0001 |
| 8 | MESNA | 1 | 0.0001 |
| 9 | ATEZOLIZUMAB | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Potassium Binder [EPC] | 3 | 0.0002 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 3 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 4 | Bile Acid [EPC] | 2 | 0.0001 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 6 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |